About Helix
Helix is a company based in San Francisco (United States) founded in 2015 by James Lu. It operates as a Data-as-a-Service, Professional Services, and HealthTech. Helix has raised $435 million across 4 funding rounds from investors including Illumina, Kleiner Perkins and NIH. Helix offers products and services including Helix Research Network, Helix Precision Pathway, Helix Diagnostics, Helix Genomic Advantage, and Helix GenoSphere. Helix operates in a competitive market with competitors including 23andMe, Benchling, Genuity Science, Counsyl and BioAge Labs, among others.
- Headquarter San Francisco, United States
- Founders James Lu
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Helix, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$435 M (USD)
in 4 rounds
-
Latest Funding Round
$50 M (USD), Series C
Jun 03, 2021
-
Investors
Illumina
& 8 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Helix
Helix offers a comprehensive portfolio of products and services, including Helix Research Network, Helix Precision Pathway, Helix Diagnostics, Helix Genomic Advantage, and Helix GenoSphere.
Genomic discoveries are accelerated for clinical impact.
Clinical decisions are enhanced with genomic insights.
Comprehensive genomic insights are provided for patients.
Healthcare costs are reduced for health plans.
Clinico-genomic cohorts are accessed for drug innovation.
People of Helix
Unlock access to complete
Unlock access to complete
Funding Insights of Helix
Helix has successfully raised a total of $435M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $50 million completed in June 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Helix
Helix has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Illumina, Kleiner Perkins and NIH.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multi-stage private equity investments are pursued across diverse sectors.
|
Locked | Locked | Locked | |
|
Investments are directed toward innovative technology startups by DFJ Growth.
|
Locked | Locked | Locked | |
|
Venture capital firm investing in early-stage tech startups
|
Locked | Locked | Locked |
Investor details for Helix
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Helix
Investment portfolio details for Helix
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Helix
Detailed financials for Helix
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Helix Comparisons
Peer comparison for Helix
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Helix
Helix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as 23andMe, Benchling, Genuity Science, Counsyl and BioAge Labs, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits
|
|
| Locked | Locked | Locked |
Cloud-based bioinformatics platform is offered for biotech research.
|
|
| Locked | Locked | Locked |
AI-based omics data analysis solutions are provided to researchers.
|
|
| Locked | Locked | Locked |
DNA mapping for pre-pregnancy genetic testing, DNA and cancer screening
|
|
| Locked | Locked | Locked |
Bioinformatics platform is provided for biomarkers and drug discovery.
|
Detailed competitors of Helix
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Helix
Complete news archive for Helix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Helix
Helix was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Helix is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
James Lu is the current CEO of Helix. They have also founded this company.
Helix is a funded company, having raised a total of $435M across 4 funding rounds to date.
Helix is established as a leading enterprise genomics platform that transforms health and life-science organizations by leveraging genomic insights. Solutions are provided across sectors like health systems, providers, life sciences, and payers. Genomic intelligence is utilized to advance precision medicine, enhance patient care, and drive innovation in healthcare. Strategic growth is supported through expanded precision medicine capabilities, improved health outcomes, and diversified revenue streams. Healthcare economics are transformed by identifying high-risk populations and enabling targeted interventions.
Helix's top competitors include 23andMe, Benchling and BioAge Labs.
Helix offers Helix Research Network, Helix Precision Pathway, Helix Diagnostics, Helix Genomic Advantage, and Helix GenoSphere.
Helix has 9 investors. Key investors include Illumina, Kleiner Perkins, NIH, Mayo Clinic, and Warburg Pincus.